ConductScience.org, home

Paper362202

The suppressor-cell network in cancer (second of two parts).

Broder S and 1 other. N Engl J Med, 1978. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. The suppressor-cell network in cancer (second of two parts). Papers, record 362202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/362202

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The suppressor-cell network in cancer (second of two parts).
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
4.12
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Broder SS
2Waldmann TAT A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
T-LymphocytesMajor topic
Animals
B-Lymphocytes
Humans
Immune Sera
Immunity, Cellular
Immunoglobulins
Immunologic Deficiency Syndromes
Immunotherapy
Leukemia
Lymphoma
Major Histocompatibility Complex
Mice
Neoplasm Metastasis
Neoplasms, Experimental
Rabbits

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
7779726Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.Br J Cancer1995https://conductscience.org/library/papers/7779726PubMed
7426575Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.Br J Ophthalmol1980https://conductscience.org/library/papers/7426575PubMed
7046454Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.Am J Pathol1982https://conductscience.org/library/papers/7046454PubMed
6967455Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination.Infect Immun1980https://conductscience.org/library/papers/6967455PubMed
6344730Immunobiological determinants in organ transplantation.Ann R Coll Surg Engl1983https://conductscience.org/library/papers/6344730PubMed
6334550Antiperinuclear activity in lung carcinoma patients.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6334550PubMed
6238191The significance of relationship of the presence of nonspecific suppressor cells in spleens with gastric cancer-related pathology.Jpn J Surg1984https://conductscience.org/library/papers/6238191PubMed
6228243Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.Br J Cancer1983https://conductscience.org/library/papers/6228243PubMed
6219866Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis.Dig Dis Sci1983https://conductscience.org/library/papers/6219866PubMed
6205746The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6205746PubMed
3632914Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3632914PubMed
2936446The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production.Cancer Immunol Immunother1986https://conductscience.org/library/papers/2936446PubMed
92096Plasma cells and immunoglobulin-synthesis in oral precancer and cancer. Correlation with dysplasia, cancer differentiation, radio- and chemotherapy.Virchows Arch A Pathol Anat Histol1979https://conductscience.org/library/papers/92096PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/362202

GET https://conductscience.org/api/papers/v1/362202/authors